Dendritic cell-based therapeutic cancer vaccines: past, present and future

被引：60
作者：
Ahmed, Md Selim [1 ]
Bae, Yong-Soo [1 ]
机构：
[1] Sungkyunkwan Univ, Dept Biol Sci, 2066 Seobu Ro, Suwon 446740, South Korea
来源：
CLINICAL AND EXPERIMENTAL VACCINE RESEARCH | 2014年 / 3卷 / 02期
关键词：
D O I：
10.7774/cevr.2014.3.2.113
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：113 / 116
页数：4
相关论文
共 11 条
[1]   Dendritic Cell-Based Immunotherapy in Prevention and Treatment of Renal Cell Carcinoma: Efficacy, Safety, and Activity of Ad-GM.CAIX in Immunocompetent Mouse Models [J].
Birkhaeuser, Frederic D. ;
Koya, Richard C. ;
Neufeld, Caleb ;
Rampersaud, Edward N. ;
Lu, Xuyang ;
Micewicz, Ewa D. ;
Chodon, Thinle ;
Atefi, Mohammad ;
Kroeger, Nils ;
Chandramouli, Gadisetti V. R. ;
Li, Gang ;
Said, Jonathan W. ;
McBride, William H. ;
Kabbinavar, Fairooz F. ;
Ribas, Antoni ;
Pantuck, Allan J. ;
Belldegrun, Arie S. ;
Riss, Joseph .
JOURNAL OF IMMUNOTHERAPY, 2013, 36 (02) :102-111
[2]   Dendritic cells in cancer immunotherapy clinical trials: are we making progress? [J].
Butterfield, Lisa H. .
FRONTIERS IN IMMUNOLOGY, 2013, 4
[3]   Dendritic cell immunotherapy: mapping the way [J].
Figdor, CG ;
de Vries, IJM ;
Lesterhuis, WJ ;
Melief, CJM .
NATURE MEDICINE, 2004, 10 (05) :475-480
[4]   Phase I/II study of immunotherapy using autologous tumor lysate-pulsed dendritic cells in patients with metastatic renal cell carcinoma [J].
Kim, Jung Han ;
Lee, Yoon ;
Bae, Yong-Soo ;
Kim, Won Seog ;
Kim, Kihyun ;
Im, Ho Yeong ;
Kang, Won Ki ;
Park, Keunchil ;
Choi, Han Yong ;
Lee, Hyun Moo ;
Kang, Won Ki ;
Lee, Hyunah ;
Doh, Hyounmie ;
Kim, Byong-Moon ;
Kim, Chae Young ;
Jeon, ChoonJu ;
Jung, Chu Won .
CLINICAL IMMUNOLOGY, 2007, 125 (03) :257-267
[5]   DC immunotherapy is highly effective for the inhibition of tumor metastasis or recurrence, although it is not efficient for the eradication of established solid tumors [J].
Lim, Dae-Seog ;
Kim, Jeong-Hwan ;
Lee, Dong-Seong ;
Yoon, Cheol-Hee ;
Bae, Yong-Soo .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2007, 56 (11) :1817-1829
[6]   Egr2 induced during DC development acts as an intrinsic negative regulator of DC immunogenicity [J].
Miah, Mohammad Alam ;
Byeon, Se Eun ;
Ahmed, Md. Selim ;
Yoon, Cheol-Hee ;
Ha, Sang-Jun ;
Bae, Yong-Soo .
EUROPEAN JOURNAL OF IMMUNOLOGY, 2013, 43 (09) :2484-2496
[7]   CISH is induced during DC development and regulates DC-mediated CTL activation [J].
Miah, Mohammad Alam ;
Yoon, Cheol-Hee ;
Kim, Joonoh ;
Jang, Jinah ;
Seong, Young-Rim ;
Bae, Yong-Soo .
EUROPEAN JOURNAL OF IMMUNOLOGY, 2012, 42 (01) :58-68
[8]   Dendritic-Cell-Based Therapeutic Cancer Vaccines [J].
Palucka, Karolina ;
Banchereau, Jacques .
IMMUNITY, 2013, 39 (01) :38-48
[9]   Cancer immunotherapy via dendritic cells [J].
Palucka, Karolina ;
Banchereau, Jacques .
NATURE REVIEWS CANCER, 2012, 12 (04) :265-277
[10]   Decisions About Dendritic Cells: Past, Present, and Future [J].
Steinman, Ralph M. .
ANNUAL REVIEW OF IMMUNOLOGY, VOL 30, 2012, 30 :1-22
12